U of T Parkinson’s disease


U of T Libraries U of T Home Portal ROSI Campus Maps
University of TorontoTSpace
Browse
Help
Search
About
First time users
Login
TSpace Repository University of Toronto Scarborough Bioline International Legacy Collection Bioline International Legacy Collection

Item Image Preview

Title:
PARKINSON’S DISEASE – A REVIEW
Author:
Shamsideen Abayomi
Issue Date:
31-Dec-2002
Publisher:
Pan African Association of Neurological Sciences
Citation:
African Journal of Neurological Sciences (ISSN: 1015-8618) Vol 21 Num 1
Abstract (summary):
Parkinson’s disease is a common neurological condition. Environmental, genetic factors and age are important predisposing factors, but there continues to be increasing evidence for a genetic component. Apoptosis and necrosis have been implicated in the loss of the nigral neurons in patients with parkinson’s disease. Mitochondrial dysfunction, oxidative stress, the actions of excitotoxins, deficient neurotrophic support and immune mechanisms are contributory. Excessive activity of the subthalamic nucleus has also been found to contribute to the symptoms of parkinsons disease using the neurotransmitter glutamate, blockade of which might provide an effective treatment of parkinson’s disease. Treatment could be preventive, symptomatic or restorative. Neuroprotective agents prevent apoptosis by upregulating apoptosis defence gene and down regulating apoptosis promoting genes. Selegilline (deprenyl) has selective anti apoptotic properties by increasing mitochondrial energy production and reducing generation of free radicals. Free radical scavengers such as α-tocopherol, high doses of ascorbate, antioxidants such as selenium and ubiquinone, drugs inhibiting glutamate release or receptor interaction such as N- methyl 4 – valine antagonist and aspirin, which down regulate glutamate receptors have been tried without proven benefit. Non-steroidal anti-inflammatory agents and interferon β have also been tried with no documented efficacy. Except for functional neurosurgical procedures, levodopa remains the most effective replacement therapy for parkinson’s disease.

Advertisements

About garyskeete

ASHWORTH MEDICINE-Professional Medical Assisting, Doctor of Science,Legal Assistant Diploma BSc Criminal Justice
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s